GLOBAL CLINICAL LEADERSHIP

Driving the Future of Global Clinical Development Through Visionary Executive Leadership, Strategic Innovation, Operational Excellence, AI Enabled Transformation, and Patient Centered Healthcare Advancement.

About Meghann
I'm a distinguished Global Clinical Operations Executive with more than 25 years of leadership experience driving complex Phase I–III clinical development programs across biotechnology, pharmaceutical, and contract research organizations. Throughout her career, she has successfully led global clinical operations, advanced innovative therapeutic programs across oncology, CNS, rare disease, and immunology, and contributed to multiple successful NDA/BLA approvals, including the first approval in immuno-oncology

Known for strategic vision and operational excellence, Meghann has built and transformed high-performing global organizations, led enterprise-wide operational initiatives, and delivered measurable business growth through scalable operating models, cross-functional leadership, and innovative clinical development strategies. Her expertise spans global clinical operations, AI enabled clinical innovation, decentralized and hybrid clinical trials, organizational transformation, regulatory readiness, vendor governance, and executive leadership

Driven by a commitment to advancing healthcare innovation, partners with executive leadership teams to accelerate clinical development, strengthen organizational performance, and deliver sustainable value for patients, partners, and stakeholders worldwide.
LEADERSHIP HIGHLIGHT
Proven leadership in global clinical development, innovation, and regulatory-ready execution.
*
*

Senior Vice President, Global Clinical Operations                                                     Jul 2025 to Present

Senior Vice President, Global Clinical Operations                                                     Jul 2025 to Present

Serving on the Executive Leadership Team at Prenosis, leads enterprise-wide clinical operations, laboratory services, and strategic integration initiatives. She drives AI-enabled clinical development, oversees scalable operational frameworks, strengthens cross-functional collaboration, and advances operational excellence to improve clinical trial execution, organizational performance, and patient outcomes.

Strategic Advisor & Executive Consultant         Jan 2024 to Present

Strategic Advisor & Executive Consultant         Jan 2024 to Present

Provides executive advisory services to biotechnology companies and CROs, guiding clinical development strategy, operational transformation, organizational growth, and global clinical execution. Partners with executive leadership teams to optimize operating models, strengthen governance, accelerate technology adoption, and position organizations for sustainable growth in an evolving clinical development landscape.

Vice President of Clinical Operations, Global Clinical Trials                                           Jan 2024 to Jul 2025

Vice President of Clinical Operations, Global Clinical Trials                                           Jan 2024 to Jul 2025

Directed global clinical operations strategy across large-scale, multi-regional clinical programs while leading cross-functional governance, merger integration, and operational transformation initiatives. Established scalable performance frameworks supporting approximately 2,000 global clinicians and strengthened collaboration across clinical development, biomarker operations, supply chain, pharmacovigilance, and executive leadership to deliver complex clinical programs successfully.


  • Wilmington, NC, USA